JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Change of Company Name
Change of Name of the Company from Jubilant Life Sciences Limited to Jubilant Pharmova Limited01-02-2021
01-02-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation of our letter dated January 29, 2021, we enclose copies of the advertisements published on January 30, 2021, in MINT (English) and HINDUSTAN (Hindi) with respect to notice of the Board Meeting scheduled to be held on February 5, 2021.30-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Partial Early Redemption Of 4.875% Senior Notes Due 2021 By Jubilant Pharma Limited, Wholly-Owned Subsidiary Of The Company (A Company Incorporated Under The Laws Of Singapore)
We refer to our intimation dated December 30, 2020 regarding the proposed early redemption of principal amount of US$100,000,000 out of US$300,000,000 4.875% Senior Notes due 2021 (the 'Notes') issued by our material wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) ('JPL'). Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that JPL has on January 29, 2021 redeemed the principal amount of US$100,000,000 on pro-rata basis out of US$300,000,000 Notes at a redemption price of 101.21875% together with the accrued interest till date. JPL had made the first early redemption of US$100,000,000 in November 2019 and the outstanding amount of the Notes after the redemption of January 29, 2021 is US$100,000,000. This is for your information and record.30-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Schedule Of Investor Conference Call For Jubilant Life Sciences Limited - Unaudited Financial Results For The Quarter Ended December 31, 2020
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on February 5, 2021 after submission of the financial results for the quarter ended December 31, 2020 to the Stock Exchanges. Details of the Conference Call are attached.29-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Board Meeting Intimation for Intimation Of Board Meeting - February 5, 2021
JUBILANT LIFE SCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 5, 2021, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2020.29-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation of our letter dated January 21, 2021, we enclose copies of the advertisements published on January 22, 2021 in MINT (English) and HINDUSTAN (Hindi) with respect to the Notice of Record Date pursuant to the Composite Scheme of Arrangement amongst HSB Corporate Consultants Private Limited ('Transferor Company 1'), Jubilant Stock Holding Private Limited ('Transferor Company 2'), SSB Consultants & Management Services Private Limited ('Transferor Company 3'), JCPL Life Science Ventures and Holdings Private Limited ('Transferor Company 4'), JSPL Life Science Services and Holdings Private Limited ('Transferor Company 5') collectively, the 'Transferor Companies'], Jubilant Life Sciences Limited ('Demerged Company/ Transferee Company') and Jubilant Ingrevia Limited ('Resulting Company' - name of Jubilant LSI Limited changed to Jubilant Ingrevia Limited) and their respective shareholders and creditors.22-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Intimation Of Record Date Pursuant Regulation 42 Of The Sebl (Listing Obligations And Disclosure Requirements) Regulations, 2015
We wish to inform you that upon Scheme coming into effect and in consideration of the transfer and vesting of the Life Science Ingredients Undertaking from the Company into Jubilant Ingrevia Limited in terms of the Scheme, the Equity Shareholders of the Company whose names are recorded in the Register of Members and records of the Depositories as members of the Company as on the Record Date i.e. February 5, 2021 will be entitled for allotment of 1 (one) equity share of Jubilant Ingrevia Limited for every 1 (one) equity share held in Jubilant Life Sciences Limited.21-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by the shareholder as per the attachment. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the shareholder after verification of the documents received. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.20-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by Mr. Jeewan Jyoti Gupta son of Mr. Prem Sagar, Shareholder as per the attachement. Mr. Jeewan Jyoti Gupta has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.20-01-2021
JUBILANT LIFE SCIENCES LIMITED - 530019 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SPB Trustee Company Pvt Ltd & SS Trustee Company Pvt Ltd & Others20-01-2021